SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001213900-23-029227
Filing Date
2023-04-13
Accepted
2023-04-12 20:49:50
Documents
6
Period of Report
2023-04-12

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT ea176180-prem14a_enzobiochem.htm PREM14A 1632938
2 FILING FEE TABLE ea176180ex-fee_enzobiochem.htm EX-FILING FEES 9314
3 GRAPHIC image_001.jpg GRAPHIC 2972
4 GRAPHIC image_002.jpg GRAPHIC 2017
5 GRAPHIC image_003.jpg GRAPHIC 300312
6 GRAPHIC image_004.jpg GRAPHIC 331074
  Complete submission text file 0001213900-23-029227.txt   2519900
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: PREM14A | Act: 34 | File No.: 001-09974 | Film No.: 23816859
SIC: 8071 Services-Medical Laboratories